Announced
Financials
Tags
Majority
Private Equity
United Kingdom
diagnostics
Biotechnology
Acquisition
Private
Friendly
Single Bidder
Pending
Synopsis
Permira agreed to acquire a majority stake in Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, delivers innovative, customized solutions. Financial terms were not disclosed. “Quotient Sciences and its disruptive approach to pharmaceutical drug development have created a truly unique business model. With GHO’s support, the business has developed strongly in recent years and we look forward to partnering with Mark and his team in continuing to grow this exciting company,” Marcel Lacaze, Permira Principal.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.